Home
About Us
Impact
Team
Contact
Technology
Integrated Drug Creation™ Platform
Denovium™ Engine AI
SynBio platform
Partner with Us
Investors
Resources
News
Events
Media Library
Press Kit
Careers
Life at Absci
Current Openings
News
Announcements
The Power of Absci’s Platform for AI Drug Discovery Demonstrated in New Preprint Manuscript on bioRxiv
08.18.2022
Read More
All
Announcements
Blog Posts
Media Highlights
Recent Press Releases
Mar 22, 2022
Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA
Recent Press Releases
Mar 21, 2022
Absci Appoints Dr. Andreas Busch to Board of Directors
Recent Press Releases
Mar 16, 2022
Absci to Present at Global AI Conference NVIDIA GTC
Announcements
Mar 13, 2022
Antibody Biology and Engineering, Gordon Research Conference | Ventura, CA
Events
Mar 01, 2022
Absci to Participate on Synthetic Biology Enabling Drug Discovery Panel at Cowen 42nd Annual Health Care Conference
Announcements
Feb 17, 2022
Absci to Participate in Upcoming Investor Conferences
Announcements
Feb 11, 2022
Absci to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Announcements
Jan 07, 2022
ZDNet: Absci and deep learning’s quest for the perfect protein
Media Highlights
Jan 07, 2022
Fierce Biotech: Merck leans into AI with $610M in biobucks for Absci drug discovery pact
Media Highlights
« Previous
1
2
3
4
5
…
7
Next »
Find out more
Contact Us